Business Description
Pulse Biosciences Inc
NAICS : 339113
SIC : 3841
ISIN : US74587B1017
Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.11 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.02 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9.5 | |||||
| 3-Year EPS without NRI Growth Rate | 8.7 | |||||
| 3-Year FCF Growth Rate | 5.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.79 | |||||
| 9-Day RSI | 41.3 | |||||
| 14-Day RSI | 37.08 | |||||
| 6-1 Month Momentum % | 114.74 | |||||
| 12-1 Month Momentum % | 199.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.68 | |||||
| Quick Ratio | 10.68 | |||||
| Cash Ratio | 10.47 | |||||
| Days Inventory | 202.23 | |||||
| Days Payable | 71.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.4 | |||||
| Shareholder Yield % | -12.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 107777.78 | |||||
| Operating Margin % | 517322.22 | |||||
| Net Margin % | 521633.33 | |||||
| ROE % | -304.11 | |||||
| ROA % | -66.87 | |||||
| ROIC % | -235.86 | |||||
| ROC (Joel Greenblatt) % | -441.39 | |||||
| ROCE % | -73.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 205.6 | |||||
| PB Ratio | 3.63 | |||||
| Price-to-Tangible-Book | 4 | |||||
| EV-to-EBIT | -4.12 | |||||
| EV-to-EBITDA | -4.23 | |||||
| EV-to-Revenue | -21291.33 | |||||
| EV-to-Forward-Revenue | 7.94 | |||||
| EV-to-FCF | -5.51 | |||||
| Price-to-Net-Current-Asset-Value | 4.87 | |||||
| Price-to-Net-Cash | 4.99 | |||||
| Earnings Yield (Greenblatt) % | -24.27 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PLSE
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulse Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.009 | ||
| EPS (TTM) ($) | -1.22 | ||
| Beta | 0.65 | ||
| Volatility % | 132.08 | ||
| 14-Day RSI | 37.08 | ||
| 14-Day ATR ($) | 0.400317 | ||
| 20-Day SMA ($) | 4.485 | ||
| 12-1 Month Momentum % | 199.44 | ||
| 52-Week Range ($) | 1.65 - 9.69 | ||
| Shares Outstanding (Mil) | 54.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulse Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulse Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulse Biosciences Inc Frequently Asked Questions
What is Pulse Biosciences Inc(PLSE)'s stock price today?
The current price of PLSE is $4.04. The 52 week high of PLSE is $9.69 and 52 week low is $1.65.
When is next earnings date of Pulse Biosciences Inc(PLSE)?
The next earnings date of Pulse Biosciences Inc(PLSE) is 2023-11-10 Est..
Does Pulse Biosciences Inc(PLSE) pay dividends? If so, how much?
Pulse Biosciences Inc(PLSE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers